Optimal timing of endoscopy in patients with acute upper gastrointestinal bleeding.


Journal

Best practice & research. Clinical gastroenterology
ISSN: 1532-1916
Titre abrégé: Best Pract Res Clin Gastroenterol
Pays: Netherlands
ID NLM: 101120605

Informations de publication

Date de publication:
Historique:
received: 05 01 2019
accepted: 23 05 2019
entrez: 2 12 2019
pubmed: 2 12 2019
medline: 15 2 2020
Statut: ppublish

Résumé

Endoscopy is the gold standard for evaluating and treating acute upper gastrointestinal bleeding (UGIB). The optimal timing of endoscopy is a very important consideration in the overall management of UGIB, but there is on going uncertainty regarding timing of the procedure, particularly in those with more severe bleeding. This is reflected by inconsistencies between current guidelines. Although evidence suggests endoscopy should be undertaken within 24 h for all admitted patients with UGIB, a small group of patients with severe bleeding or high-risk features may require more urgent endoscopy. The exact timing of the procedure in this high-risk group remains unclear, with recent data suggesting that performing endoscopy too early may be associated with worse outcome. In this article we examine the evidence for optimal timing of endoscopy in patients presenting with UGIB and suggest a clinical approach to this important aspect of patient management.

Identifiants

pubmed: 31785731
pii: S1521-6918(19)30022-8
doi: 10.1016/j.bpg.2019.05.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101618

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Sardar Chaudhary (S)

Gastrointestinal Unit, Glasgow Royal Infirmary, Glasgow, UK.

Adrian J Stanley (AJ)

Gastrointestinal Unit, Glasgow Royal Infirmary, Glasgow, UK. Electronic address: Adrian.stanley@ggc.scot.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH